Official websites use. Share sensitive information only on official, secure websites. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
There were 47 participants in the interviews 37 patients, 2 caregivers, 8 HCPs and 32 in the validation workshops 13 patients, 7 caregivers, 12 HCPs.
Keywords: Decentralised clinical trials, Home medical testing, Patient experience, Remote medical testing, Specimen handling, Telemedicine.
Facilitating patient participation in clinical research and increasing patient diversity in clinical trials is of utmost importance for clinical research performance. The SARS-CoV-2 virus pandemic has changed healthcare including clinical trial research in many ways, including accelerating the digitalisation of healthcare systems and telemedicine. The rate of technological failure when digitalising healthcare processes can be high, while studies have shown that the involvement of patients and other users may help reduce the risk of these failures [ 6 β 8 ].
Instead, there is abundant literature on home-based rehabilitation, as well as home-based monitoring of symptoms and delivery of medicines [ 15 β 18 ]. This qualitative, exploratory, and descriptive study was conducted in three stages Fig. Firstly, a literature review was carried out to identify any gaps in the current literature regarding decentralised clinical trials.
